Gingivitis Market Report 2025

The gingivitis market size has grown strongly in recent years. It will grow from $7.12 billion in 2024 to $7.47 billion in 2025 at a compound annual growth rate (CAGR) of 5%. The growth observed during the historic period can be linked to several factors, including the rise in poor oral hygiene, the growing prevalence of hormonal changes, a higher adoption rate of scaling and root planning, an increasing demand for enzymatic therapy, and the rise in healthcare spending and dental insurance coverage.

The gingivitis market size is expected to see steady growth in the next few years. It will grow to $8.99 billion in 2029 at a compound annual growth rate (CAGR) of 4.7%. The growth projected for the forecast period can be attributed to several factors, such as the growing use of laser therapy, increased awareness of diseases, supportive regulatory environments, shifts in healthcare policies, and the rising prevalence of gum disease. Key trends during this period include advancements in biotechnology, personalized medicine, innovations in treatment methods, new developments in products and technologies, and progress in advanced antimicrobial treatments.

The growing prevalence of gum disease is expected to drive the expansion of the gingivitis market in the coming years. Gum disease is a common oral condition that involves the inflammation, infection, or deterioration of the gums and surrounding tissues, mainly caused by plaque accumulation and inadequate oral care. The rise in gum disease is largely attributed to poor oral hygiene, which leads to plaque buildup and bacterial infections. Additionally, unhealthy diets high in sugar and processed foods contribute to gum inflammation, while smoking weakens the immune system, making the gums more vulnerable to infection. Gingivitis, being the earliest stage of gum disease, plays a significant role in the increasing prevalence of the condition as it can lead to more severe forms such as periodontitis if untreated. This highlights the importance of early intervention and preventive care. For example, a report by the Office for Health Improvement & Disparities (OHID) in January 2024 showed that the percentage of adults diagnosed with gum disease increased from 4% among individuals aged 16-24 to 28% among those aged 55-64, indicating a higher prevalence with age. Consequently, the increasing rate of gum disease is contributing to the growth of the gingivitis market.

Companies in the gingivitis market are innovating by developing products such as formulated toothpaste. These toothpastes are designed with specific active ingredients to address oral health concerns such as gum inflammation, plaque buildup, and overall oral health. For instance, in February 2023, Frimline Private Limited, an India-based healthcare and personal care company, launched Dente91 She toothpaste. This innovative product contains lactoferrin, a powerful antimicrobial protein that helps protect against oral infections and inflammation. Unlike traditional toothpaste, Dente91 She is enriched with folic acid (vitamin B9) and pyridoxine (vitamin B6) to support women’s oral health during various hormonal changes, including puberty and menopause.

In October 2024, Natural Dentist LLC, a US-based oral care company, acquired Caldwell Consumer Products. This acquisition, which includes brands such as The Natural Dentist, Stim-U-Dent, Fresh ‘n Brite, and EarthPicks, aims to strengthen Natural Dentist LLC’s product portfolio and improve its supply chain efficiency. Caldwell Consumer Products, based in the US, specializes in oral care and personal health products, and the acquisition is expected to drive further innovation in holistic oral care solutions.

Major players in the gingivitis market are Procter & Gamble, Mayo Clinic, British United Provident Association Limited, Colgate-Palmolive Company, Haleon group, Bausch Health Companies Inc., American Dental Association, Kivonyx Healthcare Pvt Ltd., ICPA Health Products Limited, Alarsin Pharmaceuticals, Laboratorios KIN, Ikon remedies pvt ltd., SingleCare Services LLC, Dentulu Inc., Focus Dental Care, Perio Protect LLC, Algen Healthcare Ltd, Neuracle Lifesciences Private Limited, Dental Herb Company, and Shreeji Pharma International.

North America was the largest region in the gingivitis market in 2024. The regions covered in gingivitis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the gingivitis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Gingivitis is a widespread and mild type of gum disease (periodontal disease) that causes inflammation, redness, swelling, and bleeding of the gums, mainly due to plaque buildup along the gumline. If not treated, it can develop into more severe periodontal issues, possibly resulting in gum recession and tooth loss.

The primary treatments for gingivitis include medications, surgical interventions, and non-surgical options. Medications for gingivitis consist of antimicrobial mouthwashes, antiseptic gels, and antibiotics that help reduce inflammation, control bacterial growth, and aid in gum healing. These treatments are available through various administration methods, such as oral and topical, and are distributed via retail pharmacies, hospital pharmacies, and online platforms. The end-users of these treatments include hospitals, dental clinics, and homecare settings.

The gingivitis market research report is one of a series of new reports that provides gingivitis market statistics, including gingivitis industry global market size, regional shares, competitors with a gingivitis market share, detailed gingivitis market segments, market trends and opportunities, and any further data you may need to thrive in the gingivitis industry. This gingivitis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The gingivitis market consists of revenues earned by entities providing services such as preventive dental care, periodontal therapy, and laser therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The gingivitis market also includes sales of toothpaste, mouthwashes, and interdental brushes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.